Induced pluripotent stem cells for cardiovascular disease

From product-focused disease modeling to process-focused disease discovery

Katherine A. Campbell, Andre Terzic, Timothy J Nelson

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Induced pluripotent stem (iPS) cell technology offers an unprecedented opportunity to study patient-specific disease. This biotechnology platform enables recapitulation of individualized disease signatures in a dish through differentiation of patient-derived iPS cells. Beyond disease modeling, the in vitro process of differentiation toward genuine patient tissue offers a blueprint to inform disease etiology and molecular pathogenesis. Here, we highlight recent advances in patient-specific cardiac disease modeling and outline the future promise of iPS cell-based disease discovery applications.

Original languageEnglish (US)
Pages (from-to)773-783
Number of pages11
JournalRegenerative Medicine
Volume10
Issue number6
DOIs
StatePublished - Sep 1 2015

Fingerprint

Induced Pluripotent Stem Cells
Stem cells
Cardiovascular Diseases
Blueprints
Biotechnology
Heart Diseases
Technology
Tissue

Keywords

  • cardiomyocyte
  • cardiomyopathy
  • channelopathy
  • disease discovery
  • disease modeling
  • disease pathogenesis
  • induced pluripotent-stem cell
  • regenerative medicine

ASJC Scopus subject areas

  • Biomedical Engineering
  • Embryology

Cite this

@article{76fed9425b1b476f985e004955ef1f77,
title = "Induced pluripotent stem cells for cardiovascular disease: From product-focused disease modeling to process-focused disease discovery",
abstract = "Induced pluripotent stem (iPS) cell technology offers an unprecedented opportunity to study patient-specific disease. This biotechnology platform enables recapitulation of individualized disease signatures in a dish through differentiation of patient-derived iPS cells. Beyond disease modeling, the in vitro process of differentiation toward genuine patient tissue offers a blueprint to inform disease etiology and molecular pathogenesis. Here, we highlight recent advances in patient-specific cardiac disease modeling and outline the future promise of iPS cell-based disease discovery applications.",
keywords = "cardiomyocyte, cardiomyopathy, channelopathy, disease discovery, disease modeling, disease pathogenesis, induced pluripotent-stem cell, regenerative medicine",
author = "Campbell, {Katherine A.} and Andre Terzic and Nelson, {Timothy J}",
year = "2015",
month = "9",
day = "1",
doi = "10.2217/rme.15.41",
language = "English (US)",
volume = "10",
pages = "773--783",
journal = "Regenerative Medicine",
issn = "1746-0751",
publisher = "Future Medicine Ltd.",
number = "6",

}

TY - JOUR

T1 - Induced pluripotent stem cells for cardiovascular disease

T2 - From product-focused disease modeling to process-focused disease discovery

AU - Campbell, Katherine A.

AU - Terzic, Andre

AU - Nelson, Timothy J

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Induced pluripotent stem (iPS) cell technology offers an unprecedented opportunity to study patient-specific disease. This biotechnology platform enables recapitulation of individualized disease signatures in a dish through differentiation of patient-derived iPS cells. Beyond disease modeling, the in vitro process of differentiation toward genuine patient tissue offers a blueprint to inform disease etiology and molecular pathogenesis. Here, we highlight recent advances in patient-specific cardiac disease modeling and outline the future promise of iPS cell-based disease discovery applications.

AB - Induced pluripotent stem (iPS) cell technology offers an unprecedented opportunity to study patient-specific disease. This biotechnology platform enables recapitulation of individualized disease signatures in a dish through differentiation of patient-derived iPS cells. Beyond disease modeling, the in vitro process of differentiation toward genuine patient tissue offers a blueprint to inform disease etiology and molecular pathogenesis. Here, we highlight recent advances in patient-specific cardiac disease modeling and outline the future promise of iPS cell-based disease discovery applications.

KW - cardiomyocyte

KW - cardiomyopathy

KW - channelopathy

KW - disease discovery

KW - disease modeling

KW - disease pathogenesis

KW - induced pluripotent-stem cell

KW - regenerative medicine

UR - http://www.scopus.com/inward/record.url?scp=84946750088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946750088&partnerID=8YFLogxK

U2 - 10.2217/rme.15.41

DO - 10.2217/rme.15.41

M3 - Article

VL - 10

SP - 773

EP - 783

JO - Regenerative Medicine

JF - Regenerative Medicine

SN - 1746-0751

IS - 6

ER -